Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 296

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

341	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	02/04/2014 11:13:02 AM
340	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	02/04/2014 10:47:16 AM
339	$NVLX - Nuvilex Restructures its Operations to	stocklegend	02/04/2014 10:03:55 AM
338	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/04/2014 9:27:09 AM
337	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	02/04/2014 9:08:30 AM
336	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	02/04/2014 8:54:06 AM
335	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	02/03/2014 3:41:01 PM
334	$NVLX Nuvilex Completes Acquisition of	stocklegend	02/03/2014 3:27:37 PM
333	$NVLX Nuvilex Accelerates Development of	stocklegend	02/03/2014 3:17:08 PM
332	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/03/2014 2:03:06 PM
331	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/03/2014 1:51:15 PM
330	$NVLX Investors Confidently Back Nuvilex's	stocklegend	02/03/2014 1:08:20 PM
329	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/03/2014 11:45:26 AM
328	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/03/2014 11:27:11 AM
327	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/03/2014 10:15:30 AM
326	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/03/2014 9:06:03 AM
325	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/03/2014 8:37:39 AM
324	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	01/31/2014 3:07:13 PM
323	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	01/31/2014 2:54:11 PM
322	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	01/31/2014 2:14:26 PM
321	$NVLX Nuvilex Completes Acquisition of	stocklegend	01/31/2014 1:37:36 PM
320	$NVLX Nuvilex Accelerates Development of	stocklegend	01/31/2014 12:52:18 PM
319	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	01/31/2014 12:47:29 PM
318	$NVLX Nuvilex Ahead of the Curve on	stocklegend	01/31/2014 12:35:42 PM
317	$NVLX Investors Confidently Back Nuvilex's	stocklegend	01/31/2014 11:33:16 AM
316	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	01/31/2014 10:55:18 AM
315	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/31/2014 10:15:24 AM
314	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/31/2014 9:47:55 AM
313	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/31/2014 9:38:08 AM
312	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/31/2014 9:02:53 AM
311	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/31/2014 8:48:16 AM
310	$NVLX Nuvilex Ahead of the Curve on	stocklegend	01/30/2014 3:46:34 PM
309	$NVLX Investors Confidently Back Nuvilex's	stocklegend	01/30/2014 3:22:19 PM
308	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	01/30/2014 3:01:59 PM
307	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	01/30/2014 2:29:34 PM
306	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	01/30/2014 1:52:13 PM
305	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	01/30/2014 1:16:44 PM
304	$NVLX Nuvilex Begins Making Moves at its	stocklegend	01/30/2014 12:34:49 PM
303	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	01/30/2014 12:16:25 PM
302	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	01/30/2014 11:19:33 AM
301	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	01/30/2014 10:57:48 AM
300	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	01/30/2014 10:43:17 AM
299	$NVLX - Nuvilex Restructures its Operations to	stocklegend	01/30/2014 10:07:21 AM
298	$NVLX - Nuvilex Restructures to Focus on	stocklegend	01/30/2014 9:40:14 AM
297	NVLX news:	stocklegend	01/30/2014 9:23:35 AM
296	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	01/30/2014 8:47:34 AM
295	$NVLX Inno Biologics Begins Cell Cloning	stocklegend	01/29/2014 3:58:37 PM
294	$NVLX Nuvilex Announces Cloning of Cells for	stocklegend	01/29/2014 2:11:23 PM
293	$NVLX Nuvilex Completes Acquisition of	stocklegend	01/29/2014 2:01:12 PM
292	$NVLX Nuvilex Accelerates Development of	stocklegend	01/29/2014 1:46:28 PM

Newer

Older

Recent Articles

• Terran Orbital Corporation Faces Class Action: Know Your Rights
• Shiba Inu's Burn Surge: What It Means for Investors
• Upexi Shares Face Decline Amid Legal Investigation Plans
• Transcode Therapeutics Faces Market Challenges Amid Stock Split
• Netflix's Stock Performance and Its Record-Breaking Events
• Akari Therapeutics Eyes Recovery After Significant Market Drop
• Corteva Achieves Record High Stock Price with Strong Outlook
• Resource Capital Corp Reaches New Highs at $16.99 Amid Growth
• Electromed's Stock Breaks Records with Strong Performance Surge
• Exelixis Achieves New Heights with Stock Surge to $36.6
• Integer Holdings Hits Record High as Market Confidence Grows
• Sinclair Broadcast Achieves Significant Growth and New Heights
• Market Trends: U.S. Stocks Lead as Equity Positioning Declines
• Meta's Instagram Merger Under Legal Spotlight: A Closer Look
• California Plans EV Subsidy Amid Federal Tax Credit Changes
• Investors Urged to Act Before PACS Group Deadline Approaches
• Investor Alert: Toronto-Dominion Bank Faces Legal Action
• Investors Urged to Act Amid WM Technology Class Action Alert
• Investors Urged to Act Ahead of Deadline in Acadia Case
• Important Class Action Details for Edwards Lifesciences Investors
• Challenges Ahead for Edwards Lifesciences After Share Decline
• Evolv Technologies Faces Turmoil with Executive Departures
• Shareholder Alert: Class Action Lawsuits Unfolding Soon
• Understanding Lockheed Martin's Major Options Trading Trends
• Massive Investor Interest Sparks Buzz Around IonQ Options
• Unveiling Smart Trades: The Surge in EQT Options
• CrowdStrike's Q3 Earnings: Recovery and Customer Confidence Looms
• Banxa Unveils Financial Results and Call Schedule for Q1 FY25
• Join Rogers Sugar Inc. for Their 2024 Q4 Results Call
• UniCredit's Strategic Move: Understanding Government Concerns
• Protect Your Investment in iLearningEngines Before Deadline
• Important Class Action Updates for Flux, Lilium, TMC, and Chipotle
• Zeta Global Holdings Under Investigation for Alleged Misconduct
• Bitcoin Faces Uncertainty: Analysts Warn of Possible Drop
• Acadia Healthcare Faces Legal Challenges Amid Patient Care Allegations
• Understanding the Mynaric AG Lawsuit and Your Rights as an Investor
• Zoom Video Stock Rises Ahead of Earnings Report Release
• Humacyte Faces Legal Challenges Over Manufacturing Compliance Issues
• PACS Group Investors Face Lawsuit Over Alleged Misconduct
• Enhancing Community Resilience: Treasure Coast Food Bank's Future
• The Future of COMPASS Pathways: Navigating Market Challenges
• DEA Clarifies Stance on Allegations Related to Cannabis Rescheduling
• Understanding Recent Options Activity for Peloton Interactive
• Understanding the Dynamics of ONEOK's Options Trades Today
• Investigating Market Sentiments Surrounding Redfin Trading
• BankFinancial Corporation Achieves New Stock Milestone
• GMM Stock Declines: A Struggle for Recovery in VR Market
• Kroger Achieves New Heights with 52-Week Stock Surge
• Peabody Energy's Strategic $2.32 Billion Coal Acquisition
• Controversy Surrounds Pump.Fun Amid Livestream Scandals